JILL DIEDRING: Open Payments
NPI 1609015346 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 20 payments from 9 companies in 2025. Trend: 2023 $836 · 2024 $863 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 1 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $96 |
| Amgen Inc. | 5 | $93 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| SCPHARMACEUTICALS INC. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $17 |
| Chiesi USA, Inc. | 1 | $14 |
Products named: JARDIANCE, REPATHA, LEQVIO, FUROSCIX, ELIQUIS, Attruby, VYNDAQEL, JUXTAPID.
Industry payments across IN — which companies pay providers there.
